Alleviating the hypoxic tumor microenvironment with MnO2-coated CeO2 nanoplatform for magnetic resonance imaging guided radiotherapy

被引:31
作者
Pi, Fen [1 ]
Deng, Xuanru [1 ]
Xue, Qian [1 ]
Zheng, Lan [1 ]
Liu, Hongxing [1 ,2 ]
Yang, Fang [1 ]
Chen, Tianfeng [1 ]
机构
[1] Jinan Univ, Dept Chem, Guangdong Prov Key Lab Funct Supramol Coordinat Ma, Guangzhou 510632, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Inst Urol, Dept Urol, Guangdong Key Lab Urol,Affiliated Hosp 1, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Radiosensitizer; Hypoxia; Core-shell nanocomposite; Antitumor; MR imaging; RATIONAL DESIGN; CANCER; RADIOSENSITIZATION; NANOTECHNOLOGY; NANOPARTICLES; DELIVERY;
D O I
10.1186/s12951-023-01850-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
BackgroundRadiotherapy is a commonly used tool in clinical practice to treat solid tumors. However, due to the unique microenvironment inside the tumor, such as high levels of GSH, overexpressed H2O2 and hypoxia, these factors can seriously affect the effectiveness of radiotherapy.ResultsTherefore, to further improve the efficiency of radiotherapy, a core-shell nanocomposite CeO2-MnO2 is designed as a novel radiosensitizer that can modulate the tumor microenvironment (TME) and thus improve the efficacy of radiation therapy. CeO2-MnO2 can act as a radiosensitizer to enhance X-ray absorption at the tumor site while triggering the response behavior associated with the tumor microenvironment. According to in vivo and in vitro experiments, the nanoparticles aggravate the killing effect on tumor cells by generating large amounts of ROS and disrupting the redox balance. In this process, the outer layer of MnO2 reacts with GSH and H2O2 in the tumor microenvironment to generate ROS and release oxygen, thus alleviating the hypoxic condition in the tumor area. Meanwhile, the manganese ions produced by degradation can enhance T1-weighted magnetic resonance imaging (MRI). In addition, CeO2-MnO2, due to its high atomic number oxide CeO2, releases a large number of electrons under the effect of radiotherapy, which further reacts with intracellular molecules to produce reactive oxygen species and enhances the killing effect on tumor cells, thus having the effect of radiotherapy sensitization. In conclusion, the nanomaterial CeO2-MnO2, as a novel radiosensitizer, greatly improves the efficiency of cancer radiation therapy by improving the lack of oxygen in tumor and responding to the tumor microenvironment, providing an effective strategy for the construction of nanosystem with radiosensitizing function.ConclusionIn conclusion, the nanomaterial CeO2-MnO2, as a novel radiosensitizer, greatly improves the efficiency of cancer radiation therapy by improving the lack of oxygen in tumor and responding to the tumor microenvironment, providing an effective strategy for the construction of nanosystems with radiosensitizing function.
引用
收藏
页数:14
相关论文
共 47 条
  • [1] Expanding global access to radiotherapy
    Atun, Rifat
    Jaffray, David A.
    Barton, Michael B.
    Bray, Freddie
    Baumann, Michael
    Vikram, Bhadrasain
    Hanna, Timothy P.
    Knaul, Felicia M.
    Lievens, Yolande
    Lui, Tracey Y. M.
    Milosevic, Michael
    O'Sullivan, Brian
    Rodin, Danielle L.
    Rosenblatt, Eduardo
    Van Dyk, Jacob
    Yap, Mei Ling
    Zubizarreta, Eduardo
    Gospodarowicz, Mary
    [J]. LANCET ONCOLOGY, 2015, 16 (10) : 1153 - 1186
  • [2] Nanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications
    Beik, Jaber
    Abed, Ziaeddin
    Ghoreishi, Fatemeh S.
    Hosseini-Nami, Samira
    Mehrzadi, Saeed
    Shakeri-Zadeh, Ali
    Kamrava, S. Kamran
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 235 : 205 - 221
  • [3] Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
    Bennie, Lindsey A.
    Feng, Jie
    Emmerson, Christopher
    Hyland, Wendy B.
    Matchett, Kyle B.
    McCarthy, Helen O.
    Coulter, Jonathan A.
    [J]. JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
  • [4] Hypoxia and cancer
    Brahimi-Horn, M. Christiane
    Chiche, Johanna
    Pouyssegur, Jacques
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (12): : 1301 - 1307
  • [5] Designing Core-Shell Gold and Selenium Nanocomposites for Cancer Radiochemotherapy
    Chang, Yanzhou
    He, Lizhen
    Li, Zhibin
    Zeng, Lilan
    Song, Zhenhuan
    Li, Penghui
    Chan, Leung
    You, Yuanyuan
    Yu, Xue-Feng
    Chu, Paul K.
    Chen, Tianfeng
    [J]. ACS NANO, 2017, 11 (05) : 4848 - 4858
  • [6] Radiotherapy toxicity
    De Ruysscher, Dirk
    Niedermann, Gabriele
    Burnet, Neil G.
    Siva, Shankar
    Lee, Anne W. M.
    Hegi-Johnson, Fiona
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [7] A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling
    Deng, Zhiqin
    Yu, Lianling
    Cao, Wenqiang
    Zheng, Wenjie
    Chen, Tianfeng
    [J]. CHEMICAL COMMUNICATIONS, 2015, 51 (13) : 2637 - 2640
  • [8] Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
    Farhood, B.
    Goradel, N. H.
    Mortezaee, K.
    Khanlarkhani, N.
    Salehi, E.
    Nashtaei, M. S.
    Mirtavoos-mahyari, H.
    Motevaseli, E.
    Shabeeb, D.
    Musa, A. E.
    Najafi, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03) : 268 - 279
  • [9] Systemic effects of local radiotherapy
    Formenti, Silvia C.
    Demaria, Sandra
    [J]. LANCET ONCOLOGY, 2009, 10 (07) : 718 - 726
  • [10] Cerium oxide nanoparticles in cancer
    Gao, Ying
    Chen, Kan
    Ma, Jin-lu
    Gao, Fei
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 835 - 840